HEADER HYDROLASE 23-MAR-22 7ZBD TITLE HALOTAG WITH TRAQ-G LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: HALOALKANE DEHALOGENASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.8.1.5; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RHODOCOCCUS SP.; SOURCE 3 ORGANISM_TAXID: 1831; SOURCE 4 GENE: DHAA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS HALOTAG, HALOALKANE DEHALOGENASE, SILICON RHODAMINE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.EMMERT,P.RIVERA-FUENTES,F.POJER,K.LAU REVDAT 5 07-FEB-24 7ZBD 1 REMARK REVDAT 4 11-OCT-23 7ZBD 1 JRNL REVDAT 3 19-JUL-23 7ZBD 1 AUTHOR JRNL REVDAT 2 05-JUL-23 7ZBD 1 JRNL REVDAT 1 01-FEB-23 7ZBD 0 JRNL AUTH S.EMMERT,G.QUARGNALI,S.THALLMAIR,P.RIVERA-FUENTES JRNL TITL A LOCALLY ACTIVATABLE SENSOR FOR ROBUST QUANTIFICATION OF JRNL TITL 2 ORGANELLAR GLUTATHIONE. JRNL REF NAT.CHEM. V. 15 1415 2023 JRNL REFN ESSN 1755-4349 JRNL PMID 37322101 JRNL DOI 10.1038/S41557-023-01249-3 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.HUBNER,G.QUARGNALI,S.THALLMAIR,P.RIVERA-FUENTES REMARK 1 TITL A LOCALLY ACTIVATABLE SENSOR FOR ROBUST QUANTIFICATION OF REMARK 1 TITL 2 ORGANELLAR GLUTATHIONE REMARK 1 REF BIORXIV 2022 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2022.04.01.486692 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.V.AFONINE,R.W.GROSSE-KUNSTLEVE,N.ECHOLS,J.J.HEADD, REMARK 1 AUTH 2 N.W.MORIARTY,M.MUSTYAKIMOV,T.C.TERWILLIGER,A.URZHUMTSEV, REMARK 1 AUTH 3 P.H.ZWART,P.D.ADAMS REMARK 1 TITL TOWARDS AUTOMATED CRYSTALLOGRAPHIC STRUCTURE REFINEMENT WITH REMARK 1 TITL 2 PHENIX.REFINE. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 68 352 2012 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 22505256 REMARK 1 DOI 10.1107/S0907444912001308 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX. REMARK 1 REF ACTA CRYSTALLOGR D STRUCT V. 75 861 2019 REMARK 1 REF 2 BIOL REMARK 1 REFN ISSN 2059-7983 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 65995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7500 - 4.8600 0.99 2727 143 0.1620 0.1740 REMARK 3 2 4.8600 - 3.8600 1.00 2673 141 0.1322 0.1661 REMARK 3 3 3.8600 - 3.3700 1.00 2627 138 0.1586 0.2246 REMARK 3 4 3.3700 - 3.0600 1.00 2666 140 0.1745 0.2028 REMARK 3 5 3.0600 - 2.8400 1.00 2625 139 0.1866 0.2012 REMARK 3 6 2.8400 - 2.6700 1.00 2630 138 0.1863 0.2123 REMARK 3 7 2.6700 - 2.5400 1.00 2651 139 0.1890 0.2501 REMARK 3 8 2.5400 - 2.4300 1.00 2619 138 0.1820 0.2353 REMARK 3 9 2.4300 - 2.3400 1.00 2623 138 0.1753 0.2100 REMARK 3 10 2.3400 - 2.2600 1.00 2620 138 0.1777 0.2094 REMARK 3 11 2.2600 - 2.1900 1.00 2632 139 0.1839 0.2179 REMARK 3 12 2.1900 - 2.1200 1.00 2634 139 0.1826 0.2184 REMARK 3 13 2.1200 - 2.0700 1.00 2633 138 0.2018 0.2617 REMARK 3 14 2.0700 - 2.0200 1.00 2561 134 0.2035 0.2220 REMARK 3 15 2.0200 - 1.9700 1.00 2638 139 0.2263 0.2818 REMARK 3 16 1.9700 - 1.9300 1.00 2630 139 0.2408 0.2785 REMARK 3 17 1.9300 - 1.8900 1.00 2586 136 0.2590 0.3265 REMARK 3 18 1.8900 - 1.8500 1.00 2597 137 0.2560 0.3094 REMARK 3 19 1.8500 - 1.8200 1.00 2610 138 0.2680 0.3156 REMARK 3 20 1.8200 - 1.7900 1.00 2614 137 0.2791 0.3030 REMARK 3 21 1.7900 - 1.7600 1.00 2621 138 0.2925 0.3064 REMARK 3 22 1.7600 - 1.7300 1.00 2590 137 0.3151 0.3533 REMARK 3 23 1.7300 - 1.7100 1.00 2600 138 0.3260 0.3224 REMARK 3 24 1.7100 - 1.6800 0.88 2287 120 0.3494 0.3833 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.198 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.022 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4962 REMARK 3 ANGLE : 1.173 6791 REMARK 3 CHIRALITY : 0.074 707 REMARK 3 PLANARITY : 0.012 883 REMARK 3 DIHEDRAL : 11.449 661 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZBD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292121432. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 127898 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.980 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.20.1_4487 REMARK 200 STARTING MODEL: 6U32 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% V/V PEG 6000, 10% ETHYLENE GLYCOL, REMARK 280 0.1M MAGNESIUM CHLORIDE HEXAHYDRATE AND 0.1M MES, PH 6, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 83.45250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.23000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 83.45250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.23000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 697 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 SER A 296 REMARK 465 GLY A 297 REMARK 465 HIS A 298 REMARK 465 HIS A 299 REMARK 465 HIS A 300 REMARK 465 HIS A 301 REMARK 465 HIS A 302 REMARK 465 HIS A 303 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLU B 3 REMARK 465 GLU B 294 REMARK 465 ILE B 295 REMARK 465 SER B 296 REMARK 465 GLY B 297 REMARK 465 HIS B 298 REMARK 465 HIS B 299 REMARK 465 HIS B 300 REMARK 465 HIS B 301 REMARK 465 HIS B 302 REMARK 465 HIS B 303 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 42 47.66 -108.79 REMARK 500 THR A 43 -158.66 -98.72 REMARK 500 GLU A 98 -94.03 -111.39 REMARK 500 ASP A 106 -129.52 55.57 REMARK 500 ARG A 153 46.15 -85.97 REMARK 500 VAL A 245 -69.08 -135.80 REMARK 500 LEU A 271 -97.74 -116.68 REMARK 500 PRO B 9 58.50 -91.50 REMARK 500 PRO B 42 45.09 -108.81 REMARK 500 GLU B 98 -91.06 -106.30 REMARK 500 ASP B 106 -135.04 56.36 REMARK 500 ARG B 153 45.84 -88.44 REMARK 500 ASP B 156 -73.03 -100.36 REMARK 500 VAL B 245 -67.67 -134.46 REMARK 500 LEU B 271 -99.97 -113.40 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZBD A 1 290 UNP P0A3G3 DHAA_RHOSO 1 290 DBREF 7ZBD B 1 290 UNP P0A3G3 DHAA_RHOSO 1 290 SEQADV 7ZBD ALA A 2 UNP P0A3G3 SER 2 ENGINEERED MUTATION SEQADV 7ZBD VAL A 47 UNP P0A3G3 LEU 47 ENGINEERED MUTATION SEQADV 7ZBD THR A 58 UNP P0A3G3 SER 58 ENGINEERED MUTATION SEQADV 7ZBD GLY A 78 UNP P0A3G3 ASP 78 ENGINEERED MUTATION SEQADV 7ZBD PHE A 87 UNP P0A3G3 TYR 87 ENGINEERED MUTATION SEQADV 7ZBD MET A 88 UNP P0A3G3 LEU 88 ENGINEERED MUTATION SEQADV 7ZBD PHE A 128 UNP P0A3G3 CYS 128 ENGINEERED MUTATION SEQADV 7ZBD THR A 155 UNP P0A3G3 ALA 155 ENGINEERED MUTATION SEQADV 7ZBD LYS A 160 UNP P0A3G3 GLU 160 ENGINEERED MUTATION SEQADV 7ZBD VAL A 167 UNP P0A3G3 ALA 167 ENGINEERED MUTATION SEQADV 7ZBD THR A 172 UNP P0A3G3 ALA 172 ENGINEERED MUTATION SEQADV 7ZBD MET A 175 UNP P0A3G3 LYS 175 ENGINEERED MUTATION SEQADV 7ZBD GLY A 176 UNP P0A3G3 CYS 176 ENGINEERED MUTATION SEQADV 7ZBD ASN A 195 UNP P0A3G3 LYS 195 ENGINEERED MUTATION SEQADV 7ZBD GLU A 224 UNP P0A3G3 ALA 224 ENGINEERED MUTATION SEQADV 7ZBD ASP A 227 UNP P0A3G3 ASN 227 ENGINEERED MUTATION SEQADV 7ZBD LYS A 257 UNP P0A3G3 GLU 257 ENGINEERED MUTATION SEQADV 7ZBD ALA A 264 UNP P0A3G3 THR 264 ENGINEERED MUTATION SEQADV 7ZBD ASN A 272 UNP P0A3G3 HIS 272 ENGINEERED MUTATION SEQADV 7ZBD LEU A 273 UNP P0A3G3 TYR 273 ENGINEERED MUTATION SEQADV 7ZBD SER A 291 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD THR A 292 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD LEU A 293 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD GLU A 294 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD ILE A 295 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD SER A 296 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD GLY A 297 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 298 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 299 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 300 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 301 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 302 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS A 303 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD ALA B 2 UNP P0A3G3 SER 2 ENGINEERED MUTATION SEQADV 7ZBD VAL B 47 UNP P0A3G3 LEU 47 ENGINEERED MUTATION SEQADV 7ZBD THR B 58 UNP P0A3G3 SER 58 ENGINEERED MUTATION SEQADV 7ZBD GLY B 78 UNP P0A3G3 ASP 78 ENGINEERED MUTATION SEQADV 7ZBD PHE B 87 UNP P0A3G3 TYR 87 ENGINEERED MUTATION SEQADV 7ZBD MET B 88 UNP P0A3G3 LEU 88 ENGINEERED MUTATION SEQADV 7ZBD PHE B 128 UNP P0A3G3 CYS 128 ENGINEERED MUTATION SEQADV 7ZBD THR B 155 UNP P0A3G3 ALA 155 ENGINEERED MUTATION SEQADV 7ZBD LYS B 160 UNP P0A3G3 GLU 160 ENGINEERED MUTATION SEQADV 7ZBD VAL B 167 UNP P0A3G3 ALA 167 ENGINEERED MUTATION SEQADV 7ZBD THR B 172 UNP P0A3G3 ALA 172 ENGINEERED MUTATION SEQADV 7ZBD MET B 175 UNP P0A3G3 LYS 175 ENGINEERED MUTATION SEQADV 7ZBD GLY B 176 UNP P0A3G3 CYS 176 ENGINEERED MUTATION SEQADV 7ZBD ASN B 195 UNP P0A3G3 LYS 195 ENGINEERED MUTATION SEQADV 7ZBD GLU B 224 UNP P0A3G3 ALA 224 ENGINEERED MUTATION SEQADV 7ZBD ASP B 227 UNP P0A3G3 ASN 227 ENGINEERED MUTATION SEQADV 7ZBD LYS B 257 UNP P0A3G3 GLU 257 ENGINEERED MUTATION SEQADV 7ZBD ALA B 264 UNP P0A3G3 THR 264 ENGINEERED MUTATION SEQADV 7ZBD ASN B 272 UNP P0A3G3 HIS 272 ENGINEERED MUTATION SEQADV 7ZBD LEU B 273 UNP P0A3G3 TYR 273 ENGINEERED MUTATION SEQADV 7ZBD SER B 291 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD THR B 292 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD LEU B 293 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD GLU B 294 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD ILE B 295 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD SER B 296 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD GLY B 297 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 298 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 299 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 300 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 301 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 302 UNP P0A3G3 EXPRESSION TAG SEQADV 7ZBD HIS B 303 UNP P0A3G3 EXPRESSION TAG SEQRES 1 A 303 MET ALA GLU ILE GLY THR GLY PHE PRO PHE ASP PRO HIS SEQRES 2 A 303 TYR VAL GLU VAL LEU GLY GLU ARG MET HIS TYR VAL ASP SEQRES 3 A 303 VAL GLY PRO ARG ASP GLY THR PRO VAL LEU PHE LEU HIS SEQRES 4 A 303 GLY ASN PRO THR SER SER TYR VAL TRP ARG ASN ILE ILE SEQRES 5 A 303 PRO HIS VAL ALA PRO THR HIS ARG CYS ILE ALA PRO ASP SEQRES 6 A 303 LEU ILE GLY MET GLY LYS SER ASP LYS PRO ASP LEU GLY SEQRES 7 A 303 TYR PHE PHE ASP ASP HIS VAL ARG PHE MET ASP ALA PHE SEQRES 8 A 303 ILE GLU ALA LEU GLY LEU GLU GLU VAL VAL LEU VAL ILE SEQRES 9 A 303 HIS ASP TRP GLY SER ALA LEU GLY PHE HIS TRP ALA LYS SEQRES 10 A 303 ARG ASN PRO GLU ARG VAL LYS GLY ILE ALA PHE MET GLU SEQRES 11 A 303 PHE ILE ARG PRO ILE PRO THR TRP ASP GLU TRP PRO GLU SEQRES 12 A 303 PHE ALA ARG GLU THR PHE GLN ALA PHE ARG THR THR ASP SEQRES 13 A 303 VAL GLY ARG LYS LEU ILE ILE ASP GLN ASN VAL PHE ILE SEQRES 14 A 303 GLU GLY THR LEU PRO MET GLY VAL VAL ARG PRO LEU THR SEQRES 15 A 303 GLU VAL GLU MET ASP HIS TYR ARG GLU PRO PHE LEU ASN SEQRES 16 A 303 PRO VAL ASP ARG GLU PRO LEU TRP ARG PHE PRO ASN GLU SEQRES 17 A 303 LEU PRO ILE ALA GLY GLU PRO ALA ASN ILE VAL ALA LEU SEQRES 18 A 303 VAL GLU GLU TYR MET ASP TRP LEU HIS GLN SER PRO VAL SEQRES 19 A 303 PRO LYS LEU LEU PHE TRP GLY THR PRO GLY VAL LEU ILE SEQRES 20 A 303 PRO PRO ALA GLU ALA ALA ARG LEU ALA LYS SER LEU PRO SEQRES 21 A 303 ASN CYS LYS ALA VAL ASP ILE GLY PRO GLY LEU ASN LEU SEQRES 22 A 303 LEU GLN GLU ASP ASN PRO ASP LEU ILE GLY SER GLU ILE SEQRES 23 A 303 ALA ARG TRP LEU SER THR LEU GLU ILE SER GLY HIS HIS SEQRES 24 A 303 HIS HIS HIS HIS SEQRES 1 B 303 MET ALA GLU ILE GLY THR GLY PHE PRO PHE ASP PRO HIS SEQRES 2 B 303 TYR VAL GLU VAL LEU GLY GLU ARG MET HIS TYR VAL ASP SEQRES 3 B 303 VAL GLY PRO ARG ASP GLY THR PRO VAL LEU PHE LEU HIS SEQRES 4 B 303 GLY ASN PRO THR SER SER TYR VAL TRP ARG ASN ILE ILE SEQRES 5 B 303 PRO HIS VAL ALA PRO THR HIS ARG CYS ILE ALA PRO ASP SEQRES 6 B 303 LEU ILE GLY MET GLY LYS SER ASP LYS PRO ASP LEU GLY SEQRES 7 B 303 TYR PHE PHE ASP ASP HIS VAL ARG PHE MET ASP ALA PHE SEQRES 8 B 303 ILE GLU ALA LEU GLY LEU GLU GLU VAL VAL LEU VAL ILE SEQRES 9 B 303 HIS ASP TRP GLY SER ALA LEU GLY PHE HIS TRP ALA LYS SEQRES 10 B 303 ARG ASN PRO GLU ARG VAL LYS GLY ILE ALA PHE MET GLU SEQRES 11 B 303 PHE ILE ARG PRO ILE PRO THR TRP ASP GLU TRP PRO GLU SEQRES 12 B 303 PHE ALA ARG GLU THR PHE GLN ALA PHE ARG THR THR ASP SEQRES 13 B 303 VAL GLY ARG LYS LEU ILE ILE ASP GLN ASN VAL PHE ILE SEQRES 14 B 303 GLU GLY THR LEU PRO MET GLY VAL VAL ARG PRO LEU THR SEQRES 15 B 303 GLU VAL GLU MET ASP HIS TYR ARG GLU PRO PHE LEU ASN SEQRES 16 B 303 PRO VAL ASP ARG GLU PRO LEU TRP ARG PHE PRO ASN GLU SEQRES 17 B 303 LEU PRO ILE ALA GLY GLU PRO ALA ASN ILE VAL ALA LEU SEQRES 18 B 303 VAL GLU GLU TYR MET ASP TRP LEU HIS GLN SER PRO VAL SEQRES 19 B 303 PRO LYS LEU LEU PHE TRP GLY THR PRO GLY VAL LEU ILE SEQRES 20 B 303 PRO PRO ALA GLU ALA ALA ARG LEU ALA LYS SER LEU PRO SEQRES 21 B 303 ASN CYS LYS ALA VAL ASP ILE GLY PRO GLY LEU ASN LEU SEQRES 22 B 303 LEU GLN GLU ASP ASN PRO ASP LEU ILE GLY SER GLU ILE SEQRES 23 B 303 ALA ARG TRP LEU SER THR LEU GLU ILE SER GLY HIS HIS SEQRES 24 B 303 HIS HIS HIS HIS HET GOL A 401 14 HET ILQ A 402 87 HET CL A 403 1 HET GOL B 401 14 HET ILU B 402 88 HET CL B 403 1 HETNAM GOL GLYCEROL HETNAM ILQ (10R)-7-AZANYL-N-[2-[2-(6-CHLORANYLHEXOXY) HETNAM 2 ILQ ETHOXY]ETHYL]-2'-CYANO-5,5-DIMETHYL-3-(METHYLAMINO)- HETNAM 3 ILQ 1'-OXIDANYLIDENE-SPIRO[BENZO[B][1]BENZOSILINE-10,3'- HETNAM 4 ILQ ISOINDOLE]-5'-CARBOXAMIDE HETNAM CL CHLORIDE ION HETNAM ILU [7-AZANYL-10-[5-[2-[2-(6-CHLORANYLHEXOXY) HETNAM 2 ILU ETHOXY]ETHYLCARBAMOYL]-2-(CYANOCARBAMOYL)PHENYL]-5,5- HETNAM 3 ILU DIMETHYL-BENZO[B][1]BENZOSILIN-3-YLIDENE]-METHYL- HETNAM 4 ILU AZANIUM HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 4 ILQ C35 H42 CL N5 O4 SI FORMUL 5 CL 2(CL 1-) FORMUL 7 ILU C35 H43 CL N5 O4 SI 1+ FORMUL 9 HOH *434(H2 O) HELIX 1 AA1 SER A 44 ARG A 49 5 6 HELIX 2 AA2 ILE A 51 VAL A 55 5 5 HELIX 3 AA3 PHE A 80 LEU A 95 1 16 HELIX 4 AA4 ASP A 106 ASN A 119 1 14 HELIX 5 AA5 THR A 137 TRP A 141 5 5 HELIX 6 AA6 PRO A 142 PHE A 144 5 3 HELIX 7 AA7 ALA A 145 ARG A 153 1 9 HELIX 8 AA8 THR A 155 ILE A 163 1 9 HELIX 9 AA9 ASN A 166 GLY A 171 1 6 HELIX 10 AB1 GLY A 171 GLY A 176 1 6 HELIX 11 AB2 THR A 182 GLU A 191 1 10 HELIX 12 AB3 PRO A 192 LEU A 194 5 3 HELIX 13 AB4 ASN A 195 ASP A 198 5 4 HELIX 14 AB5 ARG A 199 LEU A 209 1 11 HELIX 15 AB6 PRO A 215 SER A 232 1 18 HELIX 16 AB7 PRO A 248 LEU A 259 1 12 HELIX 17 AB8 LEU A 273 ASN A 278 1 6 HELIX 18 AB9 ASN A 278 THR A 292 1 15 HELIX 19 AC1 SER B 44 ARG B 49 5 6 HELIX 20 AC2 ILE B 51 ALA B 56 1 6 HELIX 21 AC3 PHE B 80 LEU B 95 1 16 HELIX 22 AC4 ASP B 106 ASN B 119 1 14 HELIX 23 AC5 THR B 137 TRP B 141 5 5 HELIX 24 AC6 ALA B 145 ARG B 153 1 9 HELIX 25 AC7 ASP B 156 ILE B 163 1 8 HELIX 26 AC8 ASN B 166 GLY B 171 1 6 HELIX 27 AC9 GLY B 171 GLY B 176 1 6 HELIX 28 AD1 THR B 182 GLU B 191 1 10 HELIX 29 AD2 PRO B 192 LEU B 194 5 3 HELIX 30 AD3 ASN B 195 ASP B 198 5 4 HELIX 31 AD4 ARG B 199 LEU B 209 1 11 HELIX 32 AD5 PRO B 215 SER B 232 1 18 HELIX 33 AD6 PRO B 248 LEU B 259 1 12 HELIX 34 AD7 LEU B 273 ASN B 278 1 6 HELIX 35 AD8 ASN B 278 THR B 292 1 15 SHEET 1 AA1 8 HIS A 13 VAL A 17 0 SHEET 2 AA1 8 GLU A 20 VAL A 27 -1 O GLU A 20 N VAL A 17 SHEET 3 AA1 8 CYS A 61 PRO A 64 -1 O CYS A 61 N VAL A 27 SHEET 4 AA1 8 VAL A 35 LEU A 38 1 N VAL A 35 O ILE A 62 SHEET 5 AA1 8 VAL A 100 HIS A 105 1 O VAL A 101 N LEU A 36 SHEET 6 AA1 8 VAL A 123 MET A 129 1 O LYS A 124 N VAL A 100 SHEET 7 AA1 8 LYS A 236 PRO A 243 1 O LEU A 237 N PHE A 128 SHEET 8 AA1 8 CYS A 262 GLY A 270 1 O VAL A 265 N LEU A 238 SHEET 1 AA2 8 HIS B 13 VAL B 17 0 SHEET 2 AA2 8 GLU B 20 VAL B 27 -1 O GLU B 20 N VAL B 17 SHEET 3 AA2 8 CYS B 61 PRO B 64 -1 O CYS B 61 N VAL B 27 SHEET 4 AA2 8 VAL B 35 LEU B 38 1 N PHE B 37 O ILE B 62 SHEET 5 AA2 8 VAL B 100 HIS B 105 1 O VAL B 101 N LEU B 36 SHEET 6 AA2 8 VAL B 123 MET B 129 1 O LYS B 124 N VAL B 100 SHEET 7 AA2 8 LYS B 236 PRO B 243 1 O LEU B 237 N PHE B 128 SHEET 8 AA2 8 CYS B 262 GLY B 270 1 O VAL B 265 N LEU B 238 LINK OD2 ASP A 106 C15 ILQ A 402 1555 1555 1.38 LINK OD2 ASP B 106 C34 ILU B 402 1555 1555 1.38 CISPEP 1 ASN A 41 PRO A 42 0 1.46 CISPEP 2 GLU A 214 PRO A 215 0 -6.77 CISPEP 3 THR A 242 PRO A 243 0 4.02 CISPEP 4 ASN B 41 PRO B 42 0 1.96 CISPEP 5 GLU B 214 PRO B 215 0 -0.73 CISPEP 6 THR B 242 PRO B 243 0 3.36 CRYST1 166.905 50.460 79.476 90.00 117.74 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005991 0.000000 0.003151 0.00000 SCALE2 0.000000 0.019818 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014216 0.00000